The invention relates to new substituted naphthyridines of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof,
wherein
R
1
and R
6
may have the meanings as described in claim
1
, as well as medicaments which contain these compounds. Further, the invention relates to methods of treating a disease selected from asthma, COPD, allergic rhinitis, adult respiratory distress syndrome, bronchitis, allergic dermatitis, contact dermatitis, idiopathic thrombocytopenic purpura, rheumatoid arthritis and allergic rhinoconjunctivitis by administrating an appropriate amount of a compound of formula 1 to a patient in need thereof.
本发明涉及一种新的取代
萘啶化合物,其
化学式为1,以及其药学上可接受的盐、对映异构体、对映体、外消旋体、
水合物或溶剂化物,其中R1和R6可以具有如权利要求1所述的含义,以及含有这些化合物的药物。此外,本发明还涉及通过向需要治疗哮喘、慢性阻塞性肺疾病、过敏性鼻炎、成人呼吸窘迫综合症、支气管炎、过敏性皮炎、接触性皮炎、特发性血小板减少性紫癜、类风湿性关节炎和过敏性鼻结膜炎的患者施用化合物1的适当剂量来治疗疾病的方法。